DaVita (DVA): analysis and statistics
Return, volatility, Sharpe ratio and risk for DaVita, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $238.85 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +33.00% |
| Total return over period | +134.19% |
| Annualized volatility | 36.70% |
| Sharpe ratio | 0.80 |
| Sortino ratio | 1.25 |
| Max drawdown | -41.43% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.73% |
| Correlation with the S&P 500 | 0.17 |
| Period range | $73.20 – $240.96 |
| Trading days analyzed | 752 |
Over the last 3.0 years, DaVita (DVA) has posted an annualized return of +33.00% with annual volatility of 36.70%, a Sharpe ratio of 0.80. Its worst stretch (max drawdown from a peak) was -41.43%. Its correlation with the S&P 500 is 0.17, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how DVA would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with DVA →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio